NPS Pharmaceuticals, Inc. (NPSP) Posts Wider than Expected Q4 Loss

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $26.3 million versus the consensus estimate of $26.17 million.

For earnings history and earnings-related data on NPS Pharmaceuticals, Inc. (NPSP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Goldman Sachs raises Europe stock earnings forecast to 15%
• Thoma Bravo to acquire Accelerant in $4B-plus all-cash deal